STL Volume 29 Number 6
A Review of the Role and Treatment of Biofilms in Skin Disorders
Learn about the role of biofilms in skin disorders like acne, atopic dermatitis, and chronic wounds. This article explores how biofilms contribute to disease pathogenesis, their resistance to antibiotics, and the latest conventional and innovative treatments aimed at targeting biofilm-associated skin conditions.
A Multimodal Approach to Acne-Induced Post-Inflammatory Hyperpigmentation: Trifarotene as a Long-Term Intervention
Discover how trifarotene, a fourth-generation retinoid, effectively treats acne and post-inflammatory hyperpigmentation (PIH). Learn about its benefits, clinical evidence, and role in managing acne sequelae.
Update on Drugs & Devices: November-December 2024
Update on Ruxolitinib phosphate cream 1.5% (Opzelura®), Roflumilast foam 0.3% (Zoryve®), Clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% fixed-dose topical gel (Cabtreo™), Lebrikizumab-lbkz (Ebglyss™ SC injection), Ustekinumab-srlf (Imuldosa™ SC/IV injection), Ustekinumab-aauz (Otulfi™ SC/IV injection), Ustekinumab biosimilar (Pyzchiva™ SC/IV injection).
